Go Pro

Zentalis Pharmaceuticals (ZNTL) Stock Chart & Stock Price History

Zentalis Pharmaceuticals logo
$4.29 +0.18 (+4.38%)
Closing price 08/12/2026 04:00 PM Eastern
Extended Trading
$4.22 -0.07 (-1.63%)
As of 07:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Zentalis Pharmaceuticals Stock Price Performance

The Zentalis Pharmaceuticals (ZNTL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 187.92%, with a year-to-date return of 217.78%. In the past month, the stock has decreased 7.14%, reflecting recent market activity.

As of the latest close, Zentalis Pharmaceuticals traded at $4.29 with a market cap of $307.47 million and volume of 559,029 shares. Five years ago, the stock traded at $52.60, representing a 91.84% decrease over that period. At the time, it had a market cap of $2.17 billion and a volume of 224,172 shares.

Receive ZNTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zentalis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+1.66%
1 Month
Performance
-7.14%
3 Month
Performance
+0.23%
Year-To-Date
Performance
+217.78%
1 Year
Performance
+187.92%
5 Year
Performance
-91.84%

ZNTL Stock Chart for Thursday, August, 13, 2026

Zentalis Pharmaceuticals Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/12/2026$4.11$4.29
+4.38%
$4.31$4.08559,029 shs$307.47 million
08/11/2026$4.15$4.11
-0.96%
$4.24$4.03401,837 shs$294.56 million
08/10/2026$4.22$4.15
-1.66%
$4.28$4.04823,831 shs$297.43 million
08/07/2026$5.00$4.22
-15.60%
$4.83$4.011.58 million shs$300.42 million
08/06/2026$4.95$5.00
+1.01%
$5.15$4.92701,420 shs$355.93 million
08/05/2026$4.88$4.95
+1.43%
$4.96$4.78578,305 shs$352.39 million
08/04/2026$4.65$4.88
+4.95%
$4.89$4.67788,670 shs$347.41 million
08/03/2026$4.74$4.65
-1.90%
$4.89$4.62820,499 shs$331.02 million
07/31/2026$4.92$4.74
-3.66%
$4.99$4.66941,179 shs$337.42 million
07/30/2026$4.67$4.92
+5.35%
$5.10$4.711.00 million shs$350.26 million
07/29/2026$4.62$4.67
+1.08%
$4.75$4.43709,432 shs$332.46 million
07/28/2026$4.51$4.62
+2.44%
$4.69$4.131.21 million shs$328.88 million
07/27/2026$4.33$4.51
+4.16%
$4.65$4.351.03 million shs$321.07 million
07/24/2026$4.45$4.33
-2.70%
$4.59$4.171.21 million shs$308.25 million
07/23/2026$4.50$4.45
-1.11%
$4.86$4.41992,446 shs$316.80 million
07/22/2026$5.01$4.50
-10.18%
$5.05$4.281.52 million shs$320.34 million
07/21/2026$5.01$5.01$5.37$5.001.78 million shs$356.66 million
07/20/2026$5.11$5.01
-1.96%
$5.58$4.961.78 million shs$356.66 million
07/17/2026$4.57$5.11
+11.82%
$5.34$4.683.55 million shs$363.78 million
07/16/2026$4.78$4.57
-4.39%
$4.79$4.46568,231 shs$325.32 million
07/15/2026$4.77$4.78
+0.21%
$4.81$4.56677,778 shs$340.29 million
07/14/2026$4.62$4.77
+3.25%
$4.79$4.58857,166 shs$339.58 million
07/13/2026$4.88$4.62
-5.33%
$4.86$4.391.17 million shs$328.88 million

This page (NASDAQ:ZNTL) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners